MoneyWorks4Me

Granules India informs about press release

18 Apr 2019 Evaluate

Granules India has informed about submission of a copy of Press Release issued by the Company for receiving the approval from US FDA for the Abbreviated New Drug Application (ANDA) filed by Granules Pharmaceuticals, Inc., a wholly owned foreign subsidiary of the company.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1765.55
Dr. Reddys Labs. 1198.20
Cipla 1307.90
Lupin 1955.80
Zydus Lifesciences 1120.65
View more..